Overview Most Watched Videos Most Searched Questions

Active multiple myeloma for non-transplant candidates is a form of multiple myeloma, a cancer that starts in plasma cells in the bone marrow. Biomarker test results help guide what comes next. For you or your loved one, whether this is a first diagnosis or the cancer has come back, compare FDA-approved treatment options.

  • Active Multiple Myeloma For Non-Transplant Candidate
  • What Tests Will I Need And Why?

Overview

 

 

An Active Multiple Myeloma for a Non-Transplant Candidate diagnosis means that your multiple myeloma is actively progressing and the abnormal plasma cells are crowding out the good cells and causing a few key issues:

 

  • Bone Damage – These cells can release substances that break down your bones, making them weak or painful.

 

  • Low Blood Counts – Since the bad cells take over, your body doesn’t have enough space to make healthy blood cells, so you might feel tired or get sick easily.

 

  • High Calcium Levels – Broken-down bones release calcium into your blood, which can cause confusion, thirst, or even kidney problems.

 

  • Kidney Trouble – The abnormal cells make harmful proteins that can damage your kidneys.

 

What Does Non-Transplant Candidate Mean?

A person with multiple myeloma is NOT typically a candidate for a stem cell transplant (also called a bone marrow transplant) if they don’t meet the criteria below:

 

  1. Younger or Healthy Adult: Age alone isn’t always a strict limit, but candidates are usually younger or in good overall health. This is because the process can be tough on the body.
  2. Have Good Organ Function: The heart, lungs, kidneys, and liver need to be working well to handle the treatment.
  3. Controlled Myeloma: The disease is usually under control with initial treatment (like chemotherapy) before the transplant.
  4. No Serious Health Conditions: People without severe medical problems like uncontrolled infections, major heart issues, or other life-threatening conditions are better candidates.
  5. Able to Handle High-Dose Therapy: Before the transplant, patients receive high-dose chemotherapy to destroy cancer cells. The body must be strong enough to recover from this.

 

Re-read this summary as needed and then tap, “Compare My Treatment Options Now“. Our unique Comparison Page will help you understand your FDA-approved treatment options including, who can help you pay for your treatment, where and how each is given and what side-effects you may experience.

Cancer.gov

Overview

Recommended Multiple Myeloma Videos

thumb
play-icon

Multiple Myeloma: Symptoms, Treatment, and Patient Care

Multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell.

thumb
play-icon

What Causes Multiple Myeloma?

Learn how an abnormal growth of plasma cells can lead to the formation of multiple myeloma

thumb
play-icon

How is Multiple Myeloma Diagnosed and What Testing is Necessary After?

What testing is involved in multiple myeloma diagnosis and treatment?

thumb
play-icon

What Are the Beginning Stages of Multiple Myeloma (MM)?

What happens in early stages of multiple myeloma?

thumb
play-icon

How is Multiple Myeloma Staged?

Watch as expert Dr. Abdullah Khan explains staging and its use, and myeloma patient and Empowerment Lead Lisa Hatfield shares how the use of staging and its factors have evolved over time.

thumb
play-icon

What is Myeloma?

Find out about what myeloma is, how it starts, symptoms, and how your specialist plans the best treatment for you.

View All Videos

Commonly Searched Questions

Active Multiple Myeloma Definition

X

Active Multiple Myeloma Definition

Active multiple myeloma is a type of blood cancer where abnormal plasma cells in the bone marrow grow uncontrollably and produce high levels of monoclonal protein (M-protein), which can cause damage to organs, such as the kidneys, and lead to symptoms like bone pain, fatigue, frequent infections, and weakness. Unlike smoldering multiple myeloma, which is asymptomatic, active myeloma is characterized by the presence of symptoms and can affect the body’s ability to produce healthy blood cells, leading to complications like anemia and kidney failure.

Cancer.org

Active Multiple Myeloma Recurrence Rate

X

Active Multiple Myeloma Recurrence Rate

Active multiple myeloma is a chronic, relapsing disease, and it often recurs after treatment. While the recurrence rate can vary based on individual factors, treatment response, and the specific characteristics of the disease, most people with multiple myeloma will experience a relapse at some point. The recurrence rate can be influenced by factors such as the patient’s age, overall health, and the specific treatments used. New therapies have improved outcomes, and many patients can live for years with multiple myeloma, although it typically remains an incurable condition. The recurrence and progression of the disease are closely monitored, with treatments adjusted to manage relapses and maintain quality of life.

Cancer.org

Active Multiple Myeloma Symptoms

X

Active Multiple Myeloma Symptoms

Active multiple myeloma can cause a variety of symptoms, including:
  • Bone pain, particularly in the back, hips, or ribs, due to bone damage or fractures.
  • Fatigue and weakness from anemia, which occurs when the bone marrow is unable to produce enough healthy red blood cells.
  • Frequent infections caused by a weakened immune system due to the abnormal plasma cells.
  • Kidney problems or kidney failure, as the abnormal proteins produced by the myeloma cells can damage the kidneys.
  • Numbness or weakness in the legs, or other neurological symptoms, due to spinal cord compression from bone damage.
      • These symptoms arise as the disease progresses and affects the body’s organs and tissues. Treatment typically focuses on managing these symptoms and slowing the progression of the disease.

      Cancer.org

Active Multiple Myeloma Treatment

X

Active Multiple Myeloma Treatment

The treatment for active multiple myeloma typically involves a combination of therapies aimed at controlling the disease, managing symptoms, and improving quality of life. Common treatment options include:
  • Chemotherapy: To target and kill myeloma cells.
  • Targeted therapy: Drugs that target specific molecules involved in the growth and survival of myeloma cells.
  • Immunotherapy: Treatments that stimulate the immune system to attack myeloma cells.
  • Stem cell transplant: A procedure to replace damaged bone marrow with healthy stem cells, often used after initial treatment to help extend remission.
  • Corticosteroids: Used to reduce inflammation and help control myeloma cell growth.
Treatment plans are tailored to the individual and may involve a combination of these therapies. The goal is to control the disease, manage symptoms like pain or kidney problems, and delay relapse.

Cancer.org

Active Multiple Myeloma Prevention

X

Active Multiple Myeloma Prevention

There is no known way to prevent active multiple myeloma. The exact cause of multiple myeloma is unclear, and while certain risk factors, such as age, family history, and previous exposure to certain chemicals or radiation, can increase the likelihood of developing the disease, it is not possible to prevent it entirely. However, maintaining overall health by avoiding known risk factors (e.g., excessive chemical exposure, smoking) and staying informed about your health may help with early detection. Regular check-ups and monitoring for individuals at higher risk can also aid in identifying the disease in its earlier, more treatable stages.

Cancer.org

Active Multiple Myeloma Survival Rate

X

Active Multiple Myeloma Survival Rate

The survival rate for active multiple myeloma can vary widely based on several factors, including the stage at diagnosis, the patient’s overall health, response to treatment, and specific characteristics of the disease. On average, the 5-year survival rate for people with multiple myeloma is approximately 54%. However, survival rates have improved in recent years due to advances in treatments such as immunotherapy, targeted therapy, and stem cell transplants, which have helped many patients live longer. Survival rates are higher for individuals who respond well to treatment and for those diagnosed at an earlier stage. Because multiple myeloma often recurs, ongoing treatment and monitoring are necessary to manage the disease.

Cancer.org

Most Frequently Asked Questions

Does the multiple myeloma survival rate apply to active multiple myeloma for non-transplant candidates?

SEER reports multiple myeloma as one group. It does not give a separate number for active multiple myeloma for non-transplant candidates. For all multiple myeloma, about 64 in 100 people (63.7%) are alive 5 years after diagnosis. Source: National Cancer Institute SEER, 2016–2022.

Which biomarker tests matter for active multiple myeloma for non-transplant candidates?

Biomarker testing for active multiple myeloma for non-transplant candidates checks a sample of tissue or blood for genes, proteins, or other molecules linked to cancer. For multiple myeloma, key markers include M Protein, Beta-2 Micro, and FLC. Results help doctors plan treatment. See the biomarker guide.

Can active multiple myeloma for non-transplant candidates come back after treatment?

Sometimes. When active multiple myeloma for non-transplant candidates comes back after treatment, doctors call it recurrence. It starts from cancer cells the first treatment did not fully remove. This does not mean the treatment was wrong.

Where can I compare treatment options for active multiple myeloma for non-transplant candidates?

XpertPatient's treatment comparison for active multiple myeloma for non-transplant candidates shows options side by side. Review it with the care team, whether this is a first diagnosis or the cancer has returned.